Diaceutics PLC DXRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 103.00
- Day Range
- GBX 102.00–104.00
- 52-Week Range
- GBX 79.00–110.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 8.72 Bil
- Volume/Avg
- 25,020 / 53,994
Key Statistics
- Price/Earnings (Normalized)
- 225.83
- Price/Sales
- 4.07
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.04%
Company Profile
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 151
- Website
- https://www.diaceutics.com
Comparables
Valuation
|
Metric
|
DXRX
|
BVXP
|
ZURA
|
|---|---|---|---|
Price/Earnings (Normalized) | 225.83 | 28.33 | — |
Price/Book Value | 2.12 | 20.31 | 2.66 |
Price/Sales | 4.07 | 17.37 | — |
Price/Cash Flow | 21.50 | 25.85 | — |
Price/Earnings
DXRX
BVXP
ZURA
Financial Strength
|
Metric
|
DXRX
|
BVXP
|
ZURA
|
|---|---|---|---|
Quick Ratio | 7.74 | 6.69 | 4.92 |
Current Ratio | 7.99 | 7.04 | 4.97 |
Interest Coverage | −5.64 | — | — |
Quick Ratio
DXRX
BVXP
ZURA
Profitability
|
Metric
|
DXRX
|
BVXP
|
ZURA
|
|---|---|---|---|
Return on Assets (Normalized) | 0.94% | 68.76% | −71.08% |
Return on Equity (Normalized) | 1.06% | 77.21% | −139.85% |
Return on Invested Capital (Normalized) | 0.52% | 76.10% | −99.89% |
Return on Assets
DXRX
BVXP
ZURA
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Bfspzlqpk | Xfnqh | $209.3 Bil | |
DHR
| Danaher Corp | Cynyfmqns | Rqymb | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Fdlrnyw | Cktft | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Jllhwlyx | Gqgcjjd | $41.5 Bil | |
A
| Agilent Technologies Inc | Qdwjmxzxq | Llr | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Vbrhmzqkq | Gngcr | $26.5 Bil | |
ICLR
| Icon PLC | Vwcdnjc | Pxjsbrk | $24.8 Bil | |
ILMN
| Illumina Inc | Whyfwcnd | Jrrrzps | $19.5 Bil | |
WAT
| Waters Corp | Npyzfnypk | Sfh | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Xbjphxgfb | Yfrcgk | $16.7 Bil |